Despite ambiguous results on the concentration of FKN in various breast cancer tissue samples, in vitro studies demonstrated the influence of FKN on the migration and invasion abilities of cancer cells mediated via the Src family kinase (Src)/focal adhesion kinase (FAK) signaling pathway following EGFR activation by ADAMs. The gene discussed is CX3CL1; the disease is cancer.